Acessibilidade
A+
A-
Institucional

SASB

Home > SASB > Controlled substances management > HC-DR-260a.2
Data pertaining to 2025
Overview Retail energy management Controlled substances management Medicine supply chain integrity Activity metrics Patient health outcomes Data security and privacy

Controlled substances management

Seta para baixo
GRI HC-DR-260a.2
Total monetary losses from legal actions related to controlled substances

The company does not specifically account for monetary losses related to lawsuits involving controlled substances.

© 2026 RaiaDrogasil – Todos os direitos reservados. Produzido por Plank